Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors
Does tuberculosis accelerate the progression of HIV disease? Evidence from basic science and epidemiology
Unscheduled cyclin B expression and p34 cdc2 activation in T lymphocytes from HIV-infected patients
Variability and evolution of Kaposi‚s sarcoma-associated herpesvirus in Europe and Africa
HIV infection perturbs DNA content of lymphoid cells: partial correction after ‚suppression‚ of virus replication
Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease
Short-term growth hormone administration at the time of opportunistic infections in HIV-positive patients
Loss of cytomegalovirus (CMV) viraemia following highly active antiretroviral therapy in the absence of specific anti-CMV therapy
Efficacy of salvage therapy containing ritonavir and saquinavir after failure of single protease inhibitor-containing regimens
Long-term evaluation of triple nucleoside therapy administered from primary HIV-1 infection
The influence of nutritional and metabolic status on progression from asymptomatic HIV infection to AIDS-defining diagnosis
Indinavir-based treatment of HIV-1 infected patients: efficacy in the central nervous system
Spread of HIV infection in a rural area of Tanzania
How soon after HIV seroconversion is antiretroviral therapy initiated?
Changes to AIDS dementia complex in the era of highly active antiretroviral therapy
The changing pattern of admissions to a London hospital of patients with HIV: 1988-1997
Sexual behaviours, perception of risk of HIV infection, and factors associated with attending HIV post-test counselling in Ethiopia
Lactoferrin inhibits HIV-1 replication in vitro and exhibits synergy when combined with zidovudine
HIV-associated non-mycobacterial sepsis-bacteraemia, before and during the highly active antiretroviral therapy era
Identification of reverse transcriptase mutations associated with HIV-1 drug resistance mainly against non-nucleoside reverse transcriptase inhibitors in treatment-naive patients
Clinical benefits of resistance assay for HIV-specific protease inhibitors: when to check and in whom?
Highly active antiretroviral therapy among drug users in Amsterdam: self-perceived reasons for not receiving therapy
Cerebrospinal fluid and plasma HIV-1 RNA stability at 4°C
Antiphospholipid antibodies are an epiphenomenon in HIV-infected patients
Immune activation and plasma viral load in HIV-infected African individuals
Reply